Clinical Trials for Medulloblastoma

Find clinical trials for medulloblastoma. Discover research opportunities and treatment options in your area.

27 Active Trials Found

Showing 27 trials on this page

Page 2 of 2

68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.

NCT ID: NCT04081701

This clinical trial is studying a special imaging test called 68-Ga DOTATATE PET/MRI to help doctors diagnose and manage certain types of brain tumors known to have somatostatin receptors, which ar...

Recruiting

Phase: PHASE4 Type: interventional Locations: New York, New York, United States, New York, New York, United States

Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors

NCT ID: NCT04337177

This clinical trial is studying a new flavored oral medication called irinotecan VAL-413 (Orotecan®) combined with another drug called temozolomide to treat children and young adults with certain t...

Recruiting

Phase: PHASE1 Type: interventional Locations: Cincinnati, Ohio, United States, Nashville, Tennessee, United States +7 more

Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined with the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).

NCT ID: NCT06607692

This clinical trial, called LuPARPed, is studying a combination treatment for children and adolescents with certain types of solid tumors that have come back or have not responded to previous treat...

Recruiting

Phase: PHASE2 Type: interventional Locations: Boadilla Del Monte, Madrid, Spain

In Vitro Models From Pediatric Brain Tumors

NCT ID: NCT06499636

This clinical trial is focused on finding better treatments for serious brain tumors in children, such as gliomas, ependymomas, and medulloblastomas. These tumors are a leading cause of cancer-rela...

Not yet recruiting

Type: observational Locations: Roma, Rome, Italy

Axitinib and Oral Metronomic Etoposide for Pediatric Children and AYA Refractory/Relapsing Medulloblastoma and Ependymoma

NCT ID: NCT06485908

This clinical trial is studying a combination of two medications, axitinib and oral metronomic etoposide, to see if they can help children, adolescents, and young adults with certain types of brain...

Not yet recruiting

Phase: PHASE1 Type: interventional

Clinical Study of Allogeneic Vγ9Vδ2 T Cells in the Treatment of Brain Malignant Glioma

NCT ID: NCT06396481

This clinical trial is investigating a new treatment method for aggressive brain tumors, specifically glioblastoma, diffuse intrinsic pontine glioma (DIPG), and medulloblastoma. These types of tumo...

Not yet recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Beijing, Beijing, China

Genetic and Molecular Risk Profiles of Pediatric Malignant Brain Tumors in China

NCT ID: NCT05672043

This clinical trial is looking at the genetic and molecular features of pediatric brain tumors, particularly focusing on a type called medulloblastoma, which is the most common malignant brain tumo...

Recruiting

Type: observational Locations: Beijing, Beijing, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions